share_log

Ladenburg Thalmann Initiates Coverage On Anebulo Pharmaceuticals with Buy Rating, Announces Price Target of $6

Ladenburg Thalmann Initiates Coverage On Anebulo Pharmaceuticals with Buy Rating, Announces Price Target of $6

拉登堡塔爾曼以買入評級啓動對Anebulo Pharmicals的報道,宣佈目標股價爲6美元
Benzinga Real-time News ·  2022/07/27 08:24

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy rating and announces Price Target of $6.

拉登堡塔爾曼分析師艾登·侯賽諾夫以買入評級開始對Anebulo Pharmicals(納斯達克股票代碼:ANEB)進行報道,並宣佈目標股價爲6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論